Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hepatoprotective Effects of Herbal Medicines Against Non-Alcoholic Fatty Liver Disease: A Systematic Review of Clinical and in Vivo Studies Publisher



Moayyedkazemi A1, 2 ; Amraei M3 ; Nejad EB4 ; Moghaddam A5 ; Karami K6 ; Baharvand P7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Razi Herbal Medicine Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  2. 2. Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
  3. 3. Department of Health Information Technology, Lorestan University of Medical Sciences, Khorramabad, Iran
  4. 4. Department of Orthopedic Surgery, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
  6. 6. Department of Nursing, School of Nursing and Midwifery, Lorestan University of Medical Sciences, Khorramabad, Iran
  7. 7. Department of Social Medicine, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

Source: Current Traditional Medicine Published:2021


Abstract

Background: In this systematic review, we mainly emphasis on the current advances on the hepatoprotective effects of medicinal herbs in the Non-alcoholic Fatty Liver Diseases (NAFLD) treatment. Methods: This review was done based on the 06-PRISMA guideline and registered in the CAMA-RADES-NC3Rs Preclinical Systematic Review and Meta-Analysis Facility (SyRF) database. We did all the research in scientific databases in some English language databases, such as Web of Sci-ence, PubMed, Scopus, Google Scholar, and EMBASE, with no limitation in time to find the in vivo and clinical investigations on hepatoprotective effects of herbal medicines on non-alcoholic fatty liver disease. The selected words and terms for our search were: “fatty liver”, “extract”, “es-sential oil”, “clinical trial”, “herbal medicine”, “medicinal plants”, and “non-alcoholic fatty liver”. Results: Out of 21230 papers, 28 papers including 21 in vivo (75.0%), and 7 clinical trials (25.0%) up to 2020, met the inclusion criteria for discussion in this systematic review. The most part used of plants were leaves (14, 50.0%), rhizome (4, 14.3%), seeds (3, 10.3%), respectively. The most formulations of medicinal herbs were extracts essential oil (9, 35.7%) followed by ethanolic extract (5, 17.8%). The most animals used in vivo studies were rats (12, 42.8%) followed by mice (9, 32.1%). The obtained results also showed that the most period of administrated by these plants were 12 weeks (6, 21.4%), 2 months (6, 21.4%), and 30 days (3, 10.7%), respectively. Conclusion: The obtained findings of the present review demonstrated that medicinal plants due to high availability, high efficacy, and low or minimal toxicity are considered as a valuable and prop-er alternative to chemical synthetic drugs to treat and prevent of NAFLD. However, further studies especially on the toxicity of these agents are required to approve these recommendations. © 2021 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver, Evidence-based Complementary and Alternative Medicine (2021)
2. Green Cardamom Supplementation Improves Serum Irisin, Glucose Indices, and Lipid Profiles in Overweight or Obese Non-Alcoholic Fatty Liver Disease Patients: A Double-Blind Randomized Placebo-Controlled Clinical Trial, BMC Complementary and Alternative Medicine (2019)
3. Flaxseed Supplementation in Non-Alcoholic Fatty Liver Disease: A Pilot Randomized, Open Labeled, Controlled Study, International Journal of Food Sciences and Nutrition (2016)
4. Recent Advances in Dietary Supplementation, in Treating Non-Alcoholic Fatty Liver Disease, World Journal of Hepatology (2015)
5. Egg Consumption and Risk of Non-Alcoholic Fatty Liver Disease, World Journal of Hepatology (2017)
6. Adherence to the Dietary Approaches to Stop Hypertension (Dash) and Risk of Nonalcoholic Fatty Liver Disease, International Journal of Food Sciences and Nutrition (2016)
7. Lower Circulating Irisin Is Associated With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
8. Galactose Intake Is Related to Nonalcoholic Fatty Liver Disease, Nutrition and Food Science (2019)
Experts (# of related papers)
View all Related Experts
Hossein Poustchi (7)
Somayyeh Asghari (1)
Other Related Docs
9. The Clinical Value of Serum Sirtuin-1 Concentration in the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease, BMC Gastroenterology (2025)
10. Allium Sativum: A Potential Natural Compound for Nafld Prevention and Treatment, Frontiers in Nutrition (2023)
11. Effects of Nigella Sativa on Glycemic Control, Lipid Profiles, and Biomarkers of Inflammatory and Oxidative Stress: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials, Phytotherapy Research (2020)
12. Hesperidin Improves Hepatic Steatosis, Hepatic Enzymes, and Metabolic and Inflammatory Parameters in Patients With Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial, Phytotherapy Research (2019)
13. Association of Allium Vegetables Intake and Non-Alcoholic Fatty Liver Disease Risk: A Case-Control Study, Nutrition and Food Science (2020)
14. Effects of Nigella Sativa Supplementation on Lipid Profiles in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials, Clinical Nutrition ESPEN (2024)
15. The Effects of Guluronic Acid (G2013), a New Emerging Treatment, on Inflammatory Factors in Nonalcoholic Steatohepatitis Patients Under in Vitro Conditions, Immunopharmacology and Immunotoxicology (2021)